Table 3.

Differences of the four CHF patient groups, sA, tA, sB and tB, at day 0 compared with days 7 and 15, respectively. Column Variable gives the names of the five measurements. The data of the five measurements for the four patient groups are given in the second, third and fifth columns, respectively. The fourth column is the list of P-values between days 0 and 7 for the four patient groups, and the sixth column gives the P-values calculated between days 0 and 15. The P-values in this table were calculated using the paired-sample t-test ⁴⁵.

Variable	sA0	sA7	sA0 vs sA7	sA15	sA0 vs sA15
Ang_II (pg/ml)	94.83±6.13	93.40±6.12	2.67E-12	70.62±5.59	1.73E-33
hs_CRP (mg/l)	8.11±1.04	7.91±1.03	1.42E-03	5.77±0.94	1.33E-34
LVESVI	54.27±4.09	53.25±3.81	6.95E-10	47.08±3.80	3.08E-30
LVEF	36.85±2.78	37.62±2.68	2.32E-04	41.62±2.38	4.43E-29
NT_proBNP (pg/l)	4318.57±298.86	4103.65±419.12	5.96E-06	3111.80±409.03	1.24E-31
Variable	tA0	tA7	tA0 vs tA7	tA15	tA0 vs tA15
Ang_II (pg/ml)	93.10±5.75	92.00±5.80	5.39E-06	71.10±8.37	5.01E-12
hs_CRP (mg/l)	8.00±1.07	7.82±1.06	1.47E-04	5.54±0.98	4.08E-19
LVESVI	54.75±4.05	53.60±3.99	4.51E-06	47.40±3.97	8.63E-17
LVEF	33.50±2.04	34.30±2.41	5.80E-05	38.60±2.82	2.17E-16
NT_proBNP (pg/l)	4300.05±287.04	3211.80±295.34	1.92E-20	2149.60±259.82	3.27E-15
Variable	sB0	sB7	sB0 vs sB7	sB15	sB0 vs sB15
Ang_II (pg/ml)	94.56±6.39	93.34±6.48	5.50E-11	47.51±6.98	9.63E-38
hs_CRP (mg/l)	8.07±1.04	7.66±1.04	2.16E-11	3.11±0.63	1.15E-33
LVESVI	53.95±3.85	52.78±3.81	6.04E-14	40.56±3.27	8.10E-35
LVEF	36.90±3.09	37.54±3.09	8.64E-07	46.37±2.46	3.74E-25
NT_proBNP (pg/l)	4321.17±301.67	3935.17±401.83	8.22E-17	2065.41±371.46	7.89E-37
Variable	tB0	tB7	tB0 vs tB7	tB15	tB0 vs tB15
Ang_II (pg/ml)	93.00±6.01	91.90±5.97	1.99E-04	48.00±8.57	6.23E-16
hs_CRP (mg/l)	7.93±1.06	7.77±1.00	4.88E-04	3.26±0.89	1.87E-11
LVESVI	54.75±3.65	53.25±3.39	3.92E-07	40.85±3.77	9.82E-18
LVEF	33.55±2.14	34.45±2.46	2.98E-04	42.55±2.87	2.97E-13
NT_proBNP (pg/l)	4300.10±286.65	3210.80±294.84	1.70E-20	1390.60±238.24	9.96E-20